231 related articles for article (PubMed ID: 4394278)
1. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
Keskiner A; Itil TM; Todt N
Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
[No Abstract] [Full Text] [Related]
2. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
[No Abstract] [Full Text] [Related]
3. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
Kiev A; Güclü B; Kulkarni AS
Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
[No Abstract] [Full Text] [Related]
4. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
Freeman H; Oktem MR; Oktem N
Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
[No Abstract] [Full Text] [Related]
5. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
Tetreault L
Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
[No Abstract] [Full Text] [Related]
6. Piperacetazine in ambulatory chronic schizophrenic patients.
Rada RT; Donlon PT
Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
[No Abstract] [Full Text] [Related]
7. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
[No Abstract] [Full Text] [Related]
8. Evaluation of butaperazine in chronic schizophrenia.
Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
[No Abstract] [Full Text] [Related]
9. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
Goldberg SC; Frosch WA; Drossman AK; Schooler NR; Johnson GF
Arch Gen Psychiatry; 1972 Apr; 26(4):367-73. PubMed ID: 4552130
[No Abstract] [Full Text] [Related]
10. A comparison of mesoridazine and chlorpromazine in chronic psychiatric patients.
Douglas KW; Hindley JP
J Clin Pharmacol J New Drugs; 1969; 9(3):176-82. PubMed ID: 4892453
[No Abstract] [Full Text] [Related]
11. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
Gendron JL; Zimmermann RL; Schiele BC
Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
[No Abstract] [Full Text] [Related]
12. Indications for high dose chlorpromazine therapy in chronic schizophrenia.
Prien RF; Levine J; Cole JO
Dis Nerv Syst; 1970 Nov; 31(11):739-45. PubMed ID: 4923151
[No Abstract] [Full Text] [Related]
13. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
Gallant DM; Bishop MP
Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
[No Abstract] [Full Text] [Related]
14. High dose trifluoperazine therapy in chronic schizophrenia.
Prien RF; Levine J; Cole JO
Am J Psychiatry; 1969 Sep; 126(3):305-13. PubMed ID: 4895559
[No Abstract] [Full Text] [Related]
15. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
Platz AR; Klett CJ; Caffey EM
Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
[No Abstract] [Full Text] [Related]
16. The relationship between blood levels of different forms of butaperazine and clinical response.
Simpson GM; Lament R; Cooper TB; Lee JH; Bruce RB
J Clin Pharmacol; 1973 Jul; 13(7):288-97. PubMed ID: 4145866
[No Abstract] [Full Text] [Related]
17. Liquid butaperazine in the treatment of chronic psychosis in a mental health clinic.
Clare G; Simeon J; Fink M
Curr Ther Res Clin Exp; 1969 Feb; 11(2):57-63. PubMed ID: 4388407
[No Abstract] [Full Text] [Related]
18. Proceedings: A comparative study of thiothixene and chlorpromazine in chronic schizophrenic patients: application of a special psychometric test battery.
Ruiz-Navarro JF; Vergara L; Deutsch M
Psychopharmacol Bull; 1976 Jan; 12(1):38-9. PubMed ID: 1108083
[No Abstract] [Full Text] [Related]
19. A controlled study of mesoridazine: an effective treatment for schizophrenia.
McIndoo MV
South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
[No Abstract] [Full Text] [Related]
20. Schizophrenic subtypes defined by response to drugs and placebo.
Goldberg SC; Mattsson NB
Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
[No Abstract] [Full Text] [Related]
[Next] [New Search]
